Latest News

Flu vaccine spinout secures a further £20m in funding

Flu vaccine spinout secures a further £20m in funding

Posted 15/01/2018

Vaccitech, an Oxford University spinout company developing a universal flu vaccine has secured £20 million in Series A financing. The round was co-led by new investors GV, Sequoia China, and existing backer Oxford Sciences Innovation, which manages a £600m fund aimed at Oxford University spinouts, and was also joined by Neptune Ventures. This brings the total amount raised by Vaccitech to £30 million since it was established in 2016. Vaccitech is commercialising the research of vaccine development specialists Adrian Hill and Sarah Gilbert, who developed the underpinning technology at the Jenner Institute.


New Year's Honours 2018

New Year's Honours 2018

Posted 03/01/2018

Congratulations to Professor Chas Bountra, Professor of Translational Medicine at the Nuffield Department of Medicine, who has been appointed OBE for services to Translational Medical Research in the New Year's Honours List 2018.  Congratulations also to Dr Jake Dunning, Honorary Visiting Research Fellow in Tropical Medicine (ERGO) who has been appointed MBE for services to Clinical Research.


News Archive

Recent Publications

Evaluation of the immunogenicity and impact on the latent HIV-1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy-treated subjects. J Int AIDS Soc, 20 (1), pp. 21171. Article

Systematic literature review and meta-analysis of the efficacy of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: methodological challenges. Malar J, 16 (1), pp. 488. Article

Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection. J Infect Dis, 217 (2), pp. 257-262. Article

Targeting TRIM5α in HIV Cure Strategies for the CRISPR-Cas9 Era. Front Immunol, 8 (NOV), pp. 1616. Article

Strategies for developing sustainable health research capacity in low and middle-income countries: a prospective, qualitative study investigating the barriers and enablers to locally led clinical trial conduct in Ethiopia, Cameroon and Sri Lanka. BMJ Open, 7 (10), pp. e017246. Article

Publications Archive